Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: new tricks for old dogs
Egor V. Shekunov, Polina D. Zlodeeva, Svetlana S. Efimova, Anna A. Muryleva, Vladimir V. Zarubaev, Alexander V. Slita, Olga S. Ostroumova
The paper investigates the antiviral effects of cyclic lipopeptides against SARS-CoV-2 by assessing their ability to inhibit membrane fusion in vitro.
Antiviral Research · Mar 2, 2023Peer-reviewedMolecular Biology